News
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
A lawsuit against genomics firm 23andMe is stirring a debate about what the proper role of government is in regulating how ...
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...
Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.
Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of ...
DNA data saved: 23andMe co-founder Anne Wojcicki has bid $305 million through a nonprofit to acquire her bankrupt company, ...
TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...
23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results